SHR-2031
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 29, 2024
A Novel PEGylated IL-2 mutein, RS2102, selectively induced Treg expansion. Results from a phase 1 randomized, double-blind, placebo-controlled, single dose ascending (SAD) study in healthy volunteers.
(EULAR 2024)
- No abstract available
Clinical • P1 data • IL2
1 to 1
Of
1
Go to page
1